Activation and pulmonary toxicity of pyrrolizidine alkaloids

https://doi.org/10.1016/0163-7258(90)90063-8Get rights and content

Abstract

Pyrrolizidine alkaloids unsaturated in the 1,2 position are hepatotoxins. Certain of them, such as monocrotaline, are also pneumotoxins, producing pulmonary arterial hypertension and right ventricular hypertrophy as a delayed response two weeks after administration. Pneumotoxicity is the result of hepatic metabolism, the lung itself being unable to bioactivate pyrrolizidine alkaloids. The changes produced in the lung following exposure to pneumotoxic pyrrolizidine alkaloids are reviewed, together with the factors and interventions which modify or influence these changes. In the main, the earliest changes are seen in vascular smooth muscle and in the interactions between smooth muscle and the endothelium.

The search to identify the pneumotoxic metabolite is reviewed. It is generally accepted that pyrroles, or dehydroalkaloids, are responsible for the toxicity of pyrrolizidines. However, the primary pyrroles are intensely reactive, hydrolyzing and polymerizing within seconds in aqueous solution. Evidence for and against the pneumotoxin being a primary pyrrole or a stabilized secondary conversion product of a primary pyrrole is discussed.

References (157)

  • T. Kato et al.

    Comparative effects of isosorbide dinitrate, prednisolone, indomethacin, and elastase on the development of monocrotaline-induced pulmonary hypertension

    Exp. molec. Path.

    (1989)
  • B. Kedzierski et al.

    The formation of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, a metabolite of pyrrolizidine alkaloids

    Chem.-Biol. Interactions

    (1986)
  • W.M. Lafranconi et al.

    Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline

    Toxicon

    (1985)
  • J.J. Lalich et al.

    Monocrotaline-induced pulmonary arteritis in rats

    J. Atheroscler. Res.

    (1962)
  • A.R. Mattocks

    Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids

    Chem.-Biol. Interactions

    (1972)
  • A.R. Mattocks et al.

    The distribution of (3H)synthanecine A bis-N-ethylcarbamate and its metabolites in the rat

    Chem.-Biol. Interactions

    (1976)
  • J.R. Allen et al.

    Antimitotic effects of dehydroretronecine pyrrole

  • J.R. Allen et al.

    Dehydroretronecine-induced rhabdomyosarcomas in rats

    Cancer Res.

    (1975)
  • R.J. Altiere et al.

    Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension

    J. Pharmac. exp. Ther.

    (1986)
  • Y.S. Bakhle

    The nature of the bradykinin inactivating system in isolated lungs

    Br. J. Pharmac.

    (1976)
  • J.M. Barnes et al.

    Lesions in the lungs and livers of rats poisoned with the pyrrolizidine alkaloid fulvine and its N-oxide

    J. Path. Bact.

    (1964)
  • E.R. Block et al.

    Mechanism of hypoxic injury to pulmonary artery endothelial cell plasma membranes

    Am. J. Physiol.

    (1989)
  • J.M. Boeynaems et al.

    Effects of changes in extra- and intracellular K+ on the endothelial production of prostacyclin

    Br. J. Pharmac.

    (1989)
  • J.S. Brum et al.

    Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs

    Circulation

    (1984)
  • L.H. Bruner et al.

    Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat

    Am. J. Physiol.

    (1983)
  • R.D. Bukoski et al.

    Differences in K+-induced relaxation of canine femoral and renal arteries

    Am. J. Physiol.

    (1983)
  • J. Burns

    The heart and pulmonary arteries in rat fed on Senecio jacobaea

    J. Path.

    (1972)
  • L. Carrillo et al.

    Monocrotaline-induced pulmonary hypertension and p-chlorophenylalanine (PCPA)

    Lab. Invest.

    (1969)
  • P.R. Cheeke

    Pyrrolizidine (Senecio) alkaloids: Toxicity, Metabolism, and Poisonous Plant Control Measures

    (1979)
  • P.R. Cheeke

    Toxicants of Plant Origin: I Alkaloids

    (1989)
  • C.F. Chesney et al.

    Endocardial fibrosis associated with monocrotaline-induced pulmonary hypertension in nonhuman primates (Macaca arctoides)

    Am. J. Vet. Res.

    (1973)
  • S.A.M. Cross et al.

    Sites of uptake of 3H-5-hydroxytryptamine in rat isolated lung

    Histochemistry

    (1974)
  • G.T. Czer et al.

    Low-dose PGI2 prevents monocrotaline-induced thromboxane production and lung injury

    J. appl. Physiol.

    (1986)
  • P.E. DiCorleto et al.

    Biochemical properties of the endothelium-derived growth factor. Comparison to other growth factors

    J. cell. Physiol.

    (1983)
  • D. Eisenstein et al.

    Attenuation of the toxicity of a pyrrolizidine alkaloid, monocrotaline, by metabolic inhibition

  • J.W. Fasules et al.

    Neither anticoagulant nor anticoagulant heparin affects monocrotaline lung injury

    J. appl. Physiol.

    (1987)
  • R.M. Fulton et al.

    Ventricular weight in cardiac hypertrophy

    Br. Heart J.

    (1952)
  • R.F. Furchgott

    The role of the endothelium in the response of vascular smooth muscle to drugs

    A. Rev. Pharmac. Toxic.

    (1984)
  • P.E. Ganey et al.

    Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole

    Am. J. Physiol.

    (1987)
  • P. Ganey et al.

    6-Ketoprostaglandin F1 and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline treated rats

    J. Toxic. environ. Hlth

    (1988)
  • P.E. Ganey et al.

    Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin

    J. Pharmac. exp. Ther.

    (1986)
  • P.E. Ganey et al.

    Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia

    Am. J. Physiol.

    (1988)
  • F. Ghodsi et al.

    Changes in pulmonary structure and function induced by monocrotaline intoxication

    Am. J. Physiol.

    (1981)
  • M.N. Gillespie et al.

    α-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs

    Res. Commun. Chem. Path. Pharmac.

    (1985)
  • M.N. Gillespie et al.

    Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats

    Am. J. Physiol.

    (1986)
  • M.N. Gillespie et al.

    Interleukin I bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension

  • C.N. Gillis et al.

    Effect of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and norepinephrine by perfused lung

    Br. J. Pharmac.

    (1978)
  • D.S. Griffin et al.

    Role of cellular calcium homeostasis in toxic liver injury induced by the pyrrolizidine alkaloid senecionine, and the alkenal, trans-4-OH-2-hexenal

    J. Biochem. Toxic.

    (1987)
  • P. Harris et al.

    The Human Pulmonary Circulation

    (1962)
  • P.N. Harris et al.

    The action of monocrotaline and retronecine

    J. Pharmac. exp. Ther.

    (1942)
  • Cited by (99)

    View all citing articles on Scopus
    View full text